Influenza virus vaccination of patients with multiple sclerosis

Multiple Sclerosis

Volumn 3, Issue 4, 1997, Pages 243-247

  Mokhtarian, Foroozan ^a  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

Influenza; Kurtzke Extended Disability Status Score; Multiple sclerosis; Peripheral blood lymphocytes; Placebo

Indexed keywords

INFLUENZA VACCINE; VIRUS ANTIBODY;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INFLUENZA; INFLUENZA VACCINATION; MALE; MULTIPLE SCLEROSIS;

EID: 0030693651     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/135245859700300405     Document Type: Article

References (3)

1. Lee S, Meiselas LE, Zingale SB, Richman R. (1960) Antibody production in Systemic lupus erytomatosus (LE) and rheumatoid arthritis. J Clin Invest 39: 1005.
2. Meiselas LE et al. (1961) Antibody production in rheumatic disease. The effect of brucella antigen. J Clin Invest 40: 1872-1881.
3. Ristow CS, Douglas G, Condemi JJ. (1978) Influenza Vaccination of Patients with Systemic Lupus Erythematosus. Annals of Internal Medicine 88: 786-789.